Cited by 49Cholesterol and Lipid MetabolismDrug Transport and Resistance MechanismsAtherosclerosis and Cardiovascular Diseases

Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation

Open access
Langmann, Thomas, Mauerer, Richard, Schmitz, Gerd·2006·Clinical Chemistry

Abstract

Background: ATP-binding cassette (ABC) transporters cause various diseases and regulate many physiologic processes, such as lipid homeostasis, iron transport, and immune mechanisms. Several ABC transporters are involved in bile acid, phospholipid, and sterol transport, and their expression is itself controlled by lipids. In addition, ABC proteins mediate drug export in tumor cells and promote the development of multidrug resistance. Methods: We created an ABC Transporter TaqMan Low-Density Array based on an Applied Biosystems 7900HT Micro Fluidic Card. We used a 2-μL reaction well with 2 ng of sample. To evaluate this method for lipidomic research and to characterize expression patterns of ABC transporters in cells relevant for atherosclerosis research, we monitored mRNA expression in human primary monocytes, in vitro–differentiated macrophages, and cells stimulated with the liver-X-receptor and retinoid-X-receptor agonists T0901317 and 9-cis retinoic acid, mimicking sterol loading. Results: The method enabled simultaneous analysis of 47 human ABC transporters and the reference gene 18S rRNA in 2 replicates of 4 samples per run. Conclusions: The new system uses only 2 ng of sample and small volumes of reagent, and the precaptured primers and probes avoided labor-intensive pipetting steps. The ABC Transporter TaqMan Low-Density Array may be a useful tool to monitor dysregulated ABC transporter mRNA profiles in human lipid disorders and cancer-related multidrug resistance and to analyze the pharmacologic and metabolic regulation of ABC transporter expression important for drug development in large-scale screening approaches.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1373/clinchem.2005.059774

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Primary human monocytes/macrophages virtually lack ABCD2 gene expression.

    “In contrast to primary mouse peritoneal macrophages, primary human monocytes/macrophages virtually lack ABCD2 gene expression [40], [41].”

    From Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice (2014) · cites this paper as [40]

    The Results say that 30 ABC transporters had detectable mRNA in human primary monocytes and refer to Table 1, but the passages available from our copy do not identify ABCD2 as expressed or unexpressed. Searches for ABCD2 and for its absence in monocytes/macrophages found no gene-specific result; the Table 1 passage contains only its caption and notes. (LLM, conf=0.72)

    Experimental — accuracy not yet measured
  • In human monocytes/macrophages, ABCD2 is virtually not expressed and therefore cannot compensate for the functional loss of ABCD1, resulting in a severe metabolic phenotype in this cell lineage of X-ALD patients.

    “In human monocytes/macrophages, ABCD2 is virtually not expressed [40] and, therefore, cannot compensate for the functional loss of ABCD1 resulting in a severe metabolic phenotype in this cell lineage of X-ALD patients [41].”

    From Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice (2014) · cites this paper as [40]

    The cited paper’s Table 1 caption describes ABC-transporter expression measurements in monocytes and macrophages, but the passages available in our copy do not give an ABCD2 result. Searches for “ABCD2” and its expression in these cells found no passage establishing that it is virtually unexpressed. The compensation and X-ALD phenotype statement is attached to a different citation, [41]. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 16

  1. Loeffler F. Die Aetiologie der Rotzkrankheit. Arb Kaiserl Gesundh Amt Berlin 1886;1:141-98.
  2. Yabuuchi E, Kosako Y, Oyaizu H, Yano I, Hotta H, Hashimoto Y, et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 1992;36:1251-75.
  3. Neubauer H, Meyer H, Finke E-J. Human glanders. Int Rev Armed Forces Med Serv 1997;70:258 -65.
  4. Srinivasan A, Kraus CN, DeShazer D, Becker PM, Dick JD, Spacek L, et al. Glanders in a military research microbiologist. N Engl J Med 2001;345: 256 -8.
  5. Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother 2004;54: 1134 -8.
  6. Arun S, Neubauer H, Gurel A, Ayyildiz G, Kuscu B, Yesildere T, et al. Equine glanders in Turkey. Vet Rec 1999;144:255-8.
  7. Krishna LV, Gupta K, Masand MR. Pathomorphological study of possible glanders in solipeds in Himachal Pradesch. Ind Vet J 1992;69:211-4.
  8. Bazargani TT, Tadjbakhs H, Badii A, Zahraei T. The outbreak of glanders in some racehorses in three states of Iran. J Equine Vet Sci 1996;16:232-6.
  9. Al-Ani FK, Al-Rawashdeh OF, Ali AH, Hassan FK. Glanders in horses: clinical, biochemical and serological studies in Iraq. Veterinarski Arhiv 1998;68: 155-62.
  10. Muhammad G, Khan MZ, Athar M. Clinico-microbiological and therapeutic aspects of glanders in equines. J Equine Sci 1998;9:93-6.
  11. Mota RA, Brito MF, Castro FJC, Massa M. Mormo em equ ¨ı ´deos nos Estados de Pernambuco e Alagoas. Pes Vet Bras 2000;20:155-9.
  12. Rotz LD, Koo D, O'Carroll PW. Bioterrorism preparedness: planning for the future. J Public Health Manag Pract 2000;6:45-9.
  13. Tomaso H, Scholz HC, Al Dahouk S, Pitt TL, Treu TM, Neubauer H. Development of 5Ј nuclease real-time PCR assays for the rapid identification of the Burkholderia mallei/Burkholderia pseudomallei complex. Diagn Mol Pathol 2004;13:247-53.
  14. Lee MA, Wang D, Yap EH. Detection and differentiation of Burkholderia pseudomallei, Burkholderia malle, and Burkholderia thailandensis by multi- plex PCR. FEMS Immunol Med Microbiol 2005;43:413-7.
  15. Thibault FM, Valade E, Vidal DR. Identification and discrimination of Burkholderia pseudomallei, B. mallei, and B. thailandensis by real-time PCR targeting type III secretion system genes. J Clin Microbiol 2004;42:5871-4. DOI: 10.1373/clinchem.2005.059196 References · DOI
  16. Schuierer M, Langmann T. Molecular diagnosis of ABC-transporter related diseases. Expert Rev Mol Diagn 2005;5:755-67.

Cited by

Sorted by citations

Authors
Langmann, T., Mauerer, R., & Schmitz, G.
Affiliations
University of Regensburg (DE)
Corresponding author
Langmann, Thomas
Venue
Clinical Chemistry
Published
2006-02-01
Volume
52
Issue
2
Pages
310-313
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W2154758696
Cited by
49
References
8
Citations by year
2026: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2015: 3 · 2014: 2 · 2013: 5 · 2012: 2
FWCI
7.46
Type
journal article
Language
en
Open access
Locations
  • Clinical Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
  • University of Regensburg Publication Server (University of Regensburg)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
ABC transporters, TaqMan Low Density Array, macrophage differentiation, foam cell formation, atherosclerosis, lipidomics, mRNA expression profiling, liver X receptor agonist, T0901317, 9-cis-retinoic acid, monocytes, multidrug resistance, lipid metabolism disorders
MeSH terms
Cell Differentiation, Cells, Cultured, Foam Cells, Humans, Leukocytes, Mononuclear, Macrophages, Polymerase Chain Reaction, ATP-Binding Cassette Transporters, Taq Polymerase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review